Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138906360> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W3138906360 endingPage "115" @default.
- W3138906360 startingPage "109" @default.
- W3138906360 abstract "INTRODUCTION Steroid-dependent (SD)/frequently relapsing (FR) nephrotic syndrome (NS) follows a relapsing and remitting course. It is also characterized by proteinuria and edema, which can significantly affect health-related quality of life (HRQOL) in children. This study evaluated the effectiveness and safety of a single dose of rituximab (RTX) as well as the impact of RTX on HRQOL in children with SDFRNS. METHODS Sixteen children with SDFRNS were enrolled in the study. Each patient was administered a single intravenous dose of RTX (375 mg/m2). Effectiveness was defined as remission of proteinuria. The side effects of RTX were monitored. HRQOL was assessed using PedsQL™ 4.0 Generic Core Scales. RESULTS All the patients completed the study. Three SDNS patients and three FRNS patients discontinued treatment over 1 to 3.25 years of follow-up. Additionally, three SDNS patients and three FRNS patients experienced 1 to 2 relapses. The mean relapse-free period was 79.0 ± 77.6 days. The mean dosages of prednisolone and other immunosuppressants required were significantly lower (P < .05, < .001) six months after treatment with RTX compared with six months before treatment. Relapse rate was significantly reduced (P < .001) after treatment with RTX. Skin rash, hypotension, and fever were observed in one child. Total health score and physical, emotional, and school functioning were significantly higher six months after treatment with RTX (P < .001). CONCLUSION A single dose of RTX is effective and safe for children with SDFRNS and can improve HRQOL, especially physical, emotional, and school functioning." @default.
- W3138906360 created "2021-03-29" @default.
- W3138906360 creator A5006074158 @default.
- W3138906360 creator A5012278873 @default.
- W3138906360 creator A5015430751 @default.
- W3138906360 creator A5026999257 @default.
- W3138906360 creator A5034953705 @default.
- W3138906360 creator A5047360668 @default.
- W3138906360 creator A5048449105 @default.
- W3138906360 creator A5050703245 @default.
- W3138906360 creator A5060282442 @default.
- W3138906360 date "2021-03-01" @default.
- W3138906360 modified "2023-09-22" @default.
- W3138906360 title "Single Dose of Rituximab in Children with Steroid-Dependent / Frequently Relapsing Nephrotic Syndrome, Clinical Efficacy and Evaluation of Health-Related Quality of Life." @default.
- W3138906360 cites W2009610992 @default.
- W3138906360 cites W2471357189 @default.
- W3138906360 cites W2616471844 @default.
- W3138906360 cites W2808954631 @default.
- W3138906360 cites W2891330311 @default.
- W3138906360 cites W2898846390 @default.
- W3138906360 cites W2909961594 @default.
- W3138906360 cites W2921304624 @default.
- W3138906360 cites W2959221871 @default.
- W3138906360 cites W2998396073 @default.
- W3138906360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33764321" @default.
- W3138906360 hasPublicationYear "2021" @default.
- W3138906360 type Work @default.
- W3138906360 sameAs 3138906360 @default.
- W3138906360 citedByCount "1" @default.
- W3138906360 countsByYear W31389063602022 @default.
- W3138906360 crossrefType "journal-article" @default.
- W3138906360 hasAuthorship W3138906360A5006074158 @default.
- W3138906360 hasAuthorship W3138906360A5012278873 @default.
- W3138906360 hasAuthorship W3138906360A5015430751 @default.
- W3138906360 hasAuthorship W3138906360A5026999257 @default.
- W3138906360 hasAuthorship W3138906360A5034953705 @default.
- W3138906360 hasAuthorship W3138906360A5047360668 @default.
- W3138906360 hasAuthorship W3138906360A5048449105 @default.
- W3138906360 hasAuthorship W3138906360A5050703245 @default.
- W3138906360 hasAuthorship W3138906360A5060282442 @default.
- W3138906360 hasConcept C126322002 @default.
- W3138906360 hasConcept C159110408 @default.
- W3138906360 hasConcept C162156334 @default.
- W3138906360 hasConcept C187212893 @default.
- W3138906360 hasConcept C197934379 @default.
- W3138906360 hasConcept C2776715498 @default.
- W3138906360 hasConcept C2778570526 @default.
- W3138906360 hasConcept C2778930706 @default.
- W3138906360 hasConcept C2779338263 @default.
- W3138906360 hasConcept C2779561371 @default.
- W3138906360 hasConcept C2779951463 @default.
- W3138906360 hasConcept C2780091579 @default.
- W3138906360 hasConcept C2780653079 @default.
- W3138906360 hasConcept C71924100 @default.
- W3138906360 hasConcept C90924648 @default.
- W3138906360 hasConceptScore W3138906360C126322002 @default.
- W3138906360 hasConceptScore W3138906360C159110408 @default.
- W3138906360 hasConceptScore W3138906360C162156334 @default.
- W3138906360 hasConceptScore W3138906360C187212893 @default.
- W3138906360 hasConceptScore W3138906360C197934379 @default.
- W3138906360 hasConceptScore W3138906360C2776715498 @default.
- W3138906360 hasConceptScore W3138906360C2778570526 @default.
- W3138906360 hasConceptScore W3138906360C2778930706 @default.
- W3138906360 hasConceptScore W3138906360C2779338263 @default.
- W3138906360 hasConceptScore W3138906360C2779561371 @default.
- W3138906360 hasConceptScore W3138906360C2779951463 @default.
- W3138906360 hasConceptScore W3138906360C2780091579 @default.
- W3138906360 hasConceptScore W3138906360C2780653079 @default.
- W3138906360 hasConceptScore W3138906360C71924100 @default.
- W3138906360 hasConceptScore W3138906360C90924648 @default.
- W3138906360 hasIssue "2" @default.
- W3138906360 hasLocation W31389063601 @default.
- W3138906360 hasOpenAccess W3138906360 @default.
- W3138906360 hasPrimaryLocation W31389063601 @default.
- W3138906360 hasVolume "1" @default.
- W3138906360 isParatext "false" @default.
- W3138906360 isRetracted "false" @default.
- W3138906360 magId "3138906360" @default.
- W3138906360 workType "article" @default.